1. Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy. Issue 7 (8th October 2013) Authors: Jaini, Ritika; Rayman, Patricia; Cohen, Peter A.; Finke, James H.; Tuohy, Vincent K. Journal: International journal of cancer Issue: Volume 134:Issue 7(2014:Apr. 01) Page Start: 1695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2). (February 2022) Authors: Soler, David C.; Kerstetter-Fogle, Amber; Young, Andrew B.; Rayman, Pat; Finke, James H.; Debanne, Sarah M.; Cooper, Kevin D.; Barnholtz-Sloan, Jill; Sloan, Andrew E.; McCormick, Thomas S. Journal: Molecular immunology Issue: Volume 142(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Myeloid-derived suppressor cells: The green light for myeloma immune escape. Issue 5 (September 2016) Authors: Malek, Ehsan; de Lima, Marcos; Letterio, John J.; Kim, Byung-Gyu; Finke, James H.; Driscoll, James J.; Giralt, Sergio A. Journal: Blood reviews Issue: Volume 30:Issue 5(2016:Sep.) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗